1Jan Kasalicky,Věra Krajská. The effect of repeated strontium-89 chloride therapy on bone pain palliation in patients with skeletal cancer metastases[J] 1998,European Journal of Nuclear Medicine(10):1362～1367
2Francesca Pons,Ramón Herranz,Alicia Garcia,Sergi Vidal-Sicart,Carles Conill,Juan José Grau,Joan Alcover,David Fuster,Jordi Setoain. Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer[J] 1997,European Journal of Nuclear Medicine(10):1210～1214
3Glen M. Blake,Maureen A. Zivanovic,Valerie J. Lewington. Measurements of the strontium plasma clearance rate in patients receiving 89Sr radionuclide therapy[J] 1989,European Journal of Nuclear Medicine(12):780～783
5Crawford ED, Kozlowski JM, Debruyne FM, et al.The use of strontium-89 for palliation of pain from bone metastases associated with hormone refractory prostate cancer[J].Urology, 1994, 44(4): 481-485.
6Friedland J.Local and systemic radiation for palliation of metastatic disease[J].Urol Clin North Am, 1999, 26(2): 391-402.
7Robinson RG,Preston DF,Spicer JA,et al.Radionuclide therapy of internal illness[J].JAMA,1984,251(10):1182-1188.
8Robinson RG,Preston DF,Schiefelbein M,et al.89Sr therapy for the palliation of pain due to osseous metastases[J].JAMA.1995,274(5):420-424.
